These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Avastin is as effective as Lucentis in treating wet age related macular degeneration, study finds. Torjesen I. BMJ; 2013 Jul 23; 347():f4678. PubMed ID: 23881948 [No Abstract] [Full Text] [Related]
4. Minister rules out use of Avastin over Lucentis for wet AMD. Kmietowicz Z. BMJ; 2015 Apr 16; 350():h2050. PubMed ID: 25882175 [No Abstract] [Full Text] [Related]
5. Why using Avastin for eye disease is so difficult. Torjesen I. BMJ; 2012 May 01; 344():e3012. PubMed ID: 22549057 [No Abstract] [Full Text] [Related]
18. [Economic evaluation of bevacizumab versus ranibizumab in neovascular age-related macular degeneration]. Li H, Li X, Xie F. Zhonghua Yan Ke Za Zhi; 2014 Jun 29; 50(6):426-33. PubMed ID: 25241975 [Abstract] [Full Text] [Related]